checkAd

     113  0 Kommentare Teradyne Reports Third Quarter 2023 Results

    Revenue and earnings above the mid-point of Q3 guidanceRevenue of $704 million in Q3'23, down 15% from Q3'22Robotics demand stabilized, Q3'23 revenue down 4% from Q3'22, up 20% from Q2'23Returned $136 million to shareholders in share repurchases and …

    • Revenue and earnings above the mid-point of Q3 guidance
    • Revenue of $704 million in Q3'23, down 15% from Q3'22
    • Robotics demand stabilized, Q3'23 revenue down 4% from Q3'22, up 20% from Q2'23
    • Returned $136 million to shareholders in share repurchases and dividends in Q3'23

    Q3'23

    Q3'22

    Q2'23

    Revenue (mil)

    $

    704

    $

    827

    $

    684

    GAAP EPS

    $

    0.78

    $

    1.10

    $

    0.73

    Non-GAAP EPS

    $

    0.80

    $

    1.15

    $

    0.79

    NORTH READING, MA / ACCESSWIRE / October 25, 2023 / Teradyne, Inc. (NASDAQ:TER) reported revenue of $704 million for the third quarter of 2023 of which $498 million was in Semiconductor Test, $83 million in System Test, $37 million in Wireless Test and $86 million in Robotics. GAAP net income for the third quarter was $128 million or $0.78 per diluted share. On a non-GAAP basis, Teradyne's net income in the third quarter was $132 million, or $0.80 per diluted share, which excluded restructuring and other charges, acquired intangible asset amortization, discrete income tax items and included the related tax impact on non-GAAP adjustments.

    "Greater than planned Robotics shipments and sequential growth in Semiconductor Test combined to drive sales and profits to the high end of our Q3 guidance range," said Teradyne CEO Greg Smith. "As we enter Q4, test demand is focused on technology investments with limited capacity expansion purchases expected in the quarter. In Robotics, demand has stabilized and we anticipate delivering second half results in-line with our July outlook, finishing the year achieving record quarterly shipments."

    Guidance for the fourth quarter of 2023 is revenue of $640 million to $700 million, with GAAP net income of $0.58 to $0.78 per diluted share and non-GAAP net income of $0.61 to $0.81 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, restructuring and other charges and includes the related tax impact on non-GAAP adjustments.

    Webcast

    A conference call to discuss the third quarter results, along with management's business outlook, will follow at 8:30 a.m. ET, Thursday, October 26, 2023. Interested investors should access the webcast at http://investors.teradyne.com/events-presentations. Presentation materials will be available starting at 8:30 a.m. ET. A replay will also be available at the website.

    Non-GAAP Results

    In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, restructuring and other, pension actuarial gains and losses, stock compensation modification expense, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne's baseline performance before gains, losses or other charges that may not be indicative of Teradyne's current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne's business plan, historical operating results and the operating results of Teradyne's competitors. Non-GAAP diluted shares include the impact of Teradyne's call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne's financial and operational performance, as well as facilitating meaningful comparisons of Teradyne's results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on "Investor Relations" and then selecting "Financials" and the "GAAP to Non-GAAP Reconciliation" link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

    About Teradyne

    Teradyne (NASDAQ:TER) test technology helps bring high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its robotics offerings include collaborative and mobile robots that help manufacturers of all sizes increase productivity, improve safety, and lower costs. In 2022, Teradyne had revenue of $3.2 billion and today employs over 6,600 people worldwide. For more information, visit teradyne.com. Teradyne is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

    Safe Harbor Statement

    This release contains forward-looking statements regarding Teradyne's future business prospects, results of operations, market conditions, earnings per share, the impact of supply chain conditions on the business, customer sales expectations, the payment of a quarterly dividend, the repurchase of Teradyne common stock pursuant to a share repurchase program, the impact of the Israel-Hamas conflict, the continued impact of the global COVID-19 pandemic, and the impact of U.S. and Chinese export and tariff laws, including regulations published by the U.S. Department of Commerce. Such statements are based on the current assumptions and expectations of Teradyne's management and are neither promises nor guarantees of future performance, events, customer sales, supply chain conditions or improvements, earnings per share, use of cash, payment of dividends, repurchases of common stock, payment of the senior convertible notes, the impact of the COVID-19 pandemic, the impact of the Israel-Hamas conflict, the impact of any tariffs or export controls imposed by the U.S. or China, compliance with trade protection measures or export restrictions, the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers, the impact of U.S. Department of Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China, or the impact of regulations published by the U.S. Department of Commerce relating to the export of semiconductors and semiconductor manufacturing equipment destined to certain end users and for certain end uses in China. There can be no assurance that management's estimates of Teradyne's future results or other forward-looking statements will be achieved. Specifically, Teradyne's 2026 earnings model is aspirational and includes many assumptions. There can be no assurance that these assumptions will be accurate or that model results will be achieved. As set forth below, there are many factors that could cause our 2026 earnings model and actual results to differ materially from those presently expected. Additionally, the current dividend and share repurchase programs may be modified, suspended or discontinued at any time.

    On October 7, 2022, the U.S. Department of Commerce published regulations restricting the export to China of advanced semiconductors, supercomputer technology, equipment for the manufacturing of advanced semiconductors and components and technology for the manufacturing in China of certain semiconductor manufacturing equipment. As previously disclosed, the restrictions impacted Teradyne's sales to certain companies in China and Teradyne's manufacturing and development operations in China. Teradyne mitigated the impact of these restrictions on its business by obtaining licenses from the Department of Commerce. On October 17, 2023, the Department of Commerce released new rules updating the exporting controls issued on October 7, 2022. The new rules which take effect on November 17, 2023 significantly limit the impact of the October 7, 2022 restrictions on Teradyne's business. However, the regulations may continue to have an adverse impact on certain actual or potential customers of Teradyne and on the global semiconductor industry. To the extent the regulations impact actual and potential customers or disrupt the global semiconductor industry, Teradyne's business and revenues will be adversely impacted.

    Important factors that could cause actual results, the 2026 earnings model, earnings per share, use of cash, dividend payments, repurchases of common stock, or payment of the senior convertible notes to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; development, delivery and acceptance of new products; the ability to grow the Robotics business; increased research and development spending; deterioration of Teradyne's financial condition; the continued impact of the COVID-19 pandemic and related government responses on the market and demand for Teradyne's products, on its contract manufacturers and supply chain, and on its workforce; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; insufficient cash flow to make required payments and pay the principal amount on the senior convertible notes; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in the Company's best interests; additional U.S. or global tax regulations or guidance; the impact of any tariffs or export controls imposed by the U.S. or China; compliance with trade protection measures or export restrictions; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the Israel-Hamas conflict; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the "Risk Factors" section of Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and Quarterly Report on Form 10-Q for the fiscal quarter ended July 2, 2023. The forward-looking statements provided by Teradyne in this press release represent management's views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management's views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne's views as of any date subsequent to the date of this release.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


    Quarter Ended Nine Months Ended

    October 1,
    2023
    July 2,
    2023
    October 2,
    2022
    October 1,
    2023
    October 2,
    2022
    Net revenues
    $ 703,732 $ 684,437 $ 827,073 $ 2,005,699 $ 2,423,209
    Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)
    305,441 281,945 341,694 848,495 976,508
    Gross profit
    398,291 402,492 485,379 1,157,204 1,446,701
    Operating expenses:
    Selling and administrative (2)
    138,330 145,695 135,632 434,979 415,351
    Engineering and development
    104,413 105,706 111,715 315,881 331,781
    Acquired intangible assets amortization
    4,720 4,825 4,729 14,348 14,663
    Restructuring and other (3)
    6,856 6,358 1,796 15,251 19,554
    Operating expenses
    254,319 262,584 253,872 780,459 781,349
    Income from operations
    143,972 139,908 231,507 376,745 665,352
    Interest and other (income) expense (4)
    (308) (4,494) 5,310 (9,022) 20,204
    Income before income taxes
    144,280 144,402 226,197 385,767 645,148
    Income tax provision
    16,164 24,352 42,712 54,069 101,948
    Net income
    $ 128,116 $ 120,050 $ 183,485 $ 331,698 $ 543,200
    Net income per common share:
    Basic
    $ 0.83 $ 0.78 $ 1.17 $ 2.14 $ 3.41
    Diluted
    $ 0.78 $ 0.73 $ 1.10 $ 2.01 $ 3.17
    Weighted average common shares - basic
    153,762 154,760 156,364 154,809 159,325
    Weighted average common shares - diluted (5)
    164,050 164,751 166,733 165,037 171,156

    Cash dividend declared per common share
    $ 0.11 $ 0.11 $ 0.11 $ 0.33 $ 0.33
    1. Cost of revenues includes:
    Quarter Ended Nine Months Ended

    October 1,
    2023
    July 2,
    2023
    October 2,
    2022
    October 1,
    2023
    October 2,
    2022
    Provision for excess and obsolete inventory
    $ 11,728 $ 5,731 $ 12,234 $ 23,069 $ 18,929
    Sale of previously written down inventory
    (1,198) (2,463) (269) (4,046) (980)
    $ 10,530 $ 3,268 $ 11,965 $ 19,023 $ 17,949

    2. For the nine months ended October 1, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne's retired CEO's outstanding equity awards in connection with his February 1, 2023 retirement.

    3. Restructuring and other consists of:

    Quarter Ended Nine Months Ended

    October 1,
    2023
    July 2,
    2023
    October 2,
    2022
    October 1,
    2023
    October 2,
    2022
    Employee severance
    $ 4,658 $ 5,140 $ 1,215 $ 11,835 $ 2,148
    Contract termination
    1,511 - - 1,511 $ -
    Litigation settlement
    - - - - 14,700
    Acquisition related expenses and compensation
    - - - - (201)
    Other
    687 1,218 581 1,905 2,907
    $ 6,856 $ 6,358 $ 1,796 $ 15,251 $ 19,554

    4. Interest and other includes

    Quarter Ended

    Nine Months Ended

    October 1,
    2023

    July 2,
    2023

    October 2,
    2022

    October 1,
    2023

    October 2,
    2022

    Pension actuarial losses $ 72 $ 53 $ - $ 125 $ -

    5. Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended October 1, 2023, July 2, 2023 and October 2, 2022, 0.6 million, 0.7 million and 1.5 million shares, respectively, have been included in diluted shares. For the nine months ended October 1, 2023 and October 2, 2022, 0.8 million and 2.0 million shares, respectively, have been included in diluted shares. For the quarters ended October 1, 2023, July 2, 2023 and October 2, 2022, diluted shares also included 9.2 million, 8.9 million and 8.3 million shares, respectively, from the convertible note hedge transaction. For the nine months ended October 1, 2023 and October 2, 2022, diluted shares included 9.0 million and 9.1 million shares, respectively, from the convertible note hedge transaction.

    CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)


    October 1,
    2023
    December 31,
    2022
    Assets
    Cash and cash equivalents
    $ 636,961 $ 854,773
    Marketable securities
    79,570 39,612
    Accounts receivable, net
    455,878 491,145
    Inventories, net
    322,632 325,019
    Prepayments
    593,366 532,962
    Other current assets
    10,952 14,404
    Total current assets
    2,099,359 2,257,915
    Property, plant and equipment, net
    436,449 418,683
    Operating lease right-of-use assets, net
    78,978 73,734
    Marketable securities
    103,911 110,777
    Deferred tax assets
    162,669 142,784
    Retirement plans assets
    11,403 11,761
    Other assets
    37,581 28,925
    Acquired intangible assets, net
    39,165 53,478
    Goodwill
    401,140 403,195
    Total assets
    $ 3,370,655 $ 3,501,252
    Liabilities
    Accounts payable
    $ 176,117 $ 139,722
    Accrued employees' compensation and withholdings
    155,246 212,266
    Deferred revenue and customer advances
    109,445 148,285
    Other accrued liabilities
    122,609 112,271
    Operating lease liabilities
    18,026 18,594
    Income taxes payable
    35,687 65,010
    Current debt
    23,529 50,115
    Total current liabilities
    640,659 746,263
    Retirement plans liabilities
    123,244 116,005
    Long-term deferred revenue and customer advances
    34,405 45,131
    Long-term other accrued liabilities
    17,114 15,981
    Deferred tax liabilities
    238 3,267
    Long-term operating lease liabilities
    69,364 64,176
    Long-term income taxes payable
    44,331 59,135
    Total liabilities
    929,355 1,049,958
    Shareholders' equity
    2,441,300 2,451,294
    Total liabilities and shareholders' equity
    $ 3,370,655 $ 3,501,252

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

    Quarter Ended Nine Months Ended
    October 1,
    2023
    October 2,
    2022
    October 1,
    2023
    October 2,
    2022
    Cash flows from operating activities:
    Net income
    $ 128,116 $ 183,485 $ 331,698 $ 543,200
    Adjustments to reconcile net income to net cash provided by operating activities:
    Depreciation
    23,627 23,442 68,858 67,902
    Stock-based compensation
    12,787 12,298 45,236 37,420
    Provision for excess and obsolete inventory
    11,728 12,234 23,069 18,929
    Amortization
    4,503 4,917 14,083 15,012
    Deferred taxes
    (10,455) (4,776) (24,026) (28,373)
    Losses (gains) on investments
    1,586 2,463 (3,159) 11,436
    Other
    80 218 (13) 740
    Changes in operating assets and liabilities
    Accounts receivable
    32,884 150,632 30,191 4,248
    Inventories
    20,240 (22,135) 6,395 (68,817)
    Prepayments and other assets
    (34,398) 420 (63,982) (94,331)
    Accounts payable and other liabilities
    28,513 (28,071) 3,999 (71,682)
    Deferred revenue and customer advances
    (14,579) (20,059) (49,517) (5,896)
    Retirement plans contributions
    (1,216) (1,279) (3,698) (3,897)
    Income taxes
    (29,069) (42,185) (42,683) (31,370)
    Net cash provided by operating activities
    174,347 271,604 336,451 394,521
    Cash flows from investing activities:
    Purchases of property, plant and equipment
    (34,604) (38,929) (115,306) (128,672)
    Purchases of marketable securities
    (38,768) (19,294) (137,786) (267,175)
    Issuance of convertible loan
    (5,000) - (5,000) -
    Proceeds from maturities of marketable securities
    49,450 42,440 71,447 182,092
    Proceeds from sales of marketable securities
    1,386 115,558 36,963 259,200
    Proceeds from life insurance
    - - 460 -
    Net cash (used for) provided by investing activities
    (27,536) 99,775 (149,222) 45,445
    Cash flows from financing activities:
    Repurchase of common stock
    (118,647) (217,201) (346,492) (750,000)
    Dividend payments
    (16,897) (17,136) (51,081) (52,578)
    Payments of convertible debt principal
    (9,277) (9,713) (26,735) (52,005)
    Payments related to net settlement of employee stock compensation awards
    (278) (207) (20,586) (32,987)
    Issuance of common stock under stock purchase and stock option plans
    17,485 12,197 34,084 28,733
    Net cash used for financing activities
    (127,614) (232,060) (410,810) (858,837)
    Effects of exchange rate changes on cash and cash equivalents
    4,556 (596) 5,769 7,418
    Increase (decrease) in cash and cash equivalents
    23,753 138,723 (217,812) (411,453)
    Cash and cash equivalents at beginning of period
    613,208 572,023 854,773 1,122,199
    Cash and cash equivalents at end of period
    $ 636,961 $ 710,746 $ 636,961 $ 710,746

    GAAP to Non-GAAP Earnings Reconciliation

    (In millions, except per share amounts)

    Quarter Ended
    October 1,
    2023
    % of Net Revenues July 2,
    2023
    % of Net Revenues October 2,
    2022
    % of Net Revenues
    Net revenues $ 703.7 $ 684.4 $ 827.1
    Gross profit GAAP and non-GAAP 398.3 56.6% 402.5 58.8% 485.4 58.7%
    Income from operations - GAAP 144.0 20.5% 139.9 20.4% 231.5 28.0%
    Restructuring and other (1) 6.9 1.0% 6.4 0.9% 1.8 0.2%
    Acquired intangible assets amortization 4.7 0.7% 4.8 0.7% 4.7 0.6%
    Income from operations - non-GAAP $ 155.6 22.1% $ 151.1 22.1% $ 238.0 28.8%

    Net Income
    per Common Share

    Net Income
    per Common Share

    Net Income
    per Common Share

    October 1,
    2023

    % of Net Revenues

    Basic

    Diluted

    July 2,
    2023

    % of Net Revenues

    Basic

    Diluted

    October 2,
    2022

    % of Net Revenues

    Basic

    Diluted

    Net income - GAAP $ 128.1 18.2 % $ 0.83 $ 0.78 $ 120.1 17.5 % $ 0.78 $ 0.73 $ 183.5 22.2 % $ 1.17 $ 1.10
    Restructuring and other (1) 6.9 1.0 % 0.04 0.04 6.4 0.9 % 0.04 0.04 1.8 0.2 % 0.01 0.01
    Acquired intangible assets amortization 4.7 0.7 % 0.03 0.03 4.8 0.7 % 0.03 0.03 4.7 0.6 % 0.03 0.03
    Pension mark-to-market adjustment (2) 0.1 0.0 % 0.00 0.00 0.1 0 0 0 - - - -
    Exclude discrete tax adjustments (4.8) -0.7 % (0.03) (0.03) 0.5 0.1 % 0.00 0.00 (0.5) -0.1 % (0.00) (0.00)
    Non-GAAP tax adjustments (3.5) -0.5 % (0.02) (0.02) (2.9) -0.4 % (0.02) (0.02) (0.3) 0.0 % (0.00) (0.00)
    Convertible share adjustment (3) - - - - - - - - - - - 0.01
    Net income - non-GAAP $ 131.5 18.7 % $ 0.86 $ 0.80 $ 129.0 18.8 % $ 0.83 $ 0.79 $ 189.2 22.9 % $ 1.21 $ 1.15
    GAAP and non-GAAP weighted average common shares - basic 153.8 154.8 156.4
    GAAP weighted average common shares - diluted 164.1 164.8 166.7

    Exclude dilutive shares related to convertible note

    transaction

    (0.6) (0.7) (1.5)
    Non-GAAP weighted average common shares - diluted 163.4 164.1 165.2
    1. Restructuring and other consists of:

    Quarter Ended

    October 1,
    2023

    July 2,
    2023

    October 2,
    2022

    Employee severance

    $ 4.7 $ 5.1 $ 1.2

    Contract termination

    1.5 - -

    Other

    0.6 1.2 0.6
    $ 6.9 $ 6.4 $ 1.8

    2. For the quarter ended October 1, 2023 and July 2, 2023 adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne's mark-to-market pension accounting.

    3. For the quarters ended October 2, 2022, the non-GAAP diluted EPS calculation adds back $0.2 million of convertible debt interest expense to non-GAAP net income. For the quarters ended October 1, 2023, July 2, 2023, and October 2, 2022, non-GAAP weighted average diluted common shares include 9.2 million, 8.9 million and 8.3 million shares, respectively, from the convertible note hedge transaction.

    Nine Months Ended

    October 1,
    2023

    % of Net Revenues

    October 2,
    2022

    % of Net Revenues

    Net Revenues

    $ 2,005.7 $ 2,423.2

    Gross profit GAAP and non-GAAP

    1,157.2 57.7 % 1,446.7 59.7 %

    Income from operations - GAAP

    376.7 18.8 % 665.4 27.5 %

    Restructuring and other (1)

    15.3 0.8 % 19.6 0.8 %

    Acquired intangible assets amortization

    14.3 0.7 % 14.7 0.6 %

    Equity modification charge (2)

    5.9 0.3 % - -

    Income from operations - non-GAAP

    $ 412.2 20.6 % $ 699.7 28.9 %

    Net Income
    per Common Share

    Net Income
    per Common Share

    October 1,
    2023

    % of Net Revenues

    Basic

    Diluted

    October 2,
    2022

    % of Net Revenues

    Basic

    Diluted

    Net income - GAAP $ 331.7 16.5 % $ 2.14 $ 2.01 $ 543.2 22.4 % $ 3.41 $ 3.17
    Restructuring and other (1) 15.3 0.8 % 0.10 0.09 19.6 0.8 % 0.12 0.11
    Acquired intangible assets amortization 14.3 0.7 % 0.09 0.09 14.7 0.6 % 0.09 0.09
    Equity modification charge (2) 5.9 0.3 % 0.04 0.04 - - - -
    Pension mark-to-market adjustment (3) 0.1 0.0 % 0.00 0.00 - - - -
    Exclude discrete tax adjustments (6.7) -0.3 % (0.04) (0.04) (9.3) -0.4 % (0.06) (0.05)
    Non-GAAP tax adjustments (8.8) -0.4 % (0.06) (0.05) (5.9) -0.2 % (0.04) (0.03)
    Convertible share adjustment (4) - - - 0.01 - - - 0.04
    Net income - non-GAAP $ 351.8 17.5 % $ 2.27 $ 2.14 $ 562.3 23.2 % $ 3.53 $ 3.33
    GAAP and non-GAAP weighted average common shares - basic 154.8 159.3
    GAAP weighted average common shares - diluted 165.0 171.2
    Exclude dilutive shares from convertible note (0.8) (2.0)
    Non-GAAP weighted average common shares - diluted 164.2 169.2
    1. Restructuring and other consists of:
    Nine Months Ended
    October 1,
    2023
    October 2,
    2022
    Employee severance
    $ 11.8 $ 2.1
    Contract termination
    1.5 -
    Acquisition related expenses and compensation
    - (0.2)
    Litigation settlement
    - 14.7
    Other
    1.9 2.9
    $ 15.3 $ 19.6

    2. For the nine months ended October 1, 2023, selling and administrative expenses include an equity charge of $5.9 million for the modification of Teradyne's retired CEO's outstanding equity awards in connection with his February 1, 2023 retirement.

    3. For the nine months ended October 1, 2023 adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne's mark-to-market pension accounting.

    4. For the nine months ended October 1, 2023, July 2, 2023 and October 2, 2022, the non-GAAP diluted EPS calculation adds back $0.2 million and $0.7 million, respectively, of convertible debt interest expense to non-GAAP net income. For the nine months ended October 1, 2023 and October 2, 2022, non-GAAP weighted average diluted common shares include 9.0 million and 9.1 million shares, respectively, related to the convertible debt hedge transaction.

    GAAP to Non-GAAP Reconciliation of Fourth Quarter 2023 guidance:

    GAAP and non-GAAP fourth quarter revenue guidance:
    $640 million to $700 million
    GAAP net income per diluted share
    $ 0.58 $ 0.78
    Exclude acquired intangible assets amortization
    0.03 0.03
    Exclude restructuring and other charges
    0.01 0.01
    Non-GAAP tax adjustments
    (0.01) (0.01)
    Non-GAAP net income per diluted share
    $ 0.61 $ 0.81

    For press releases and other information of interest to investors, please visit Teradyne's homepage at http://www.teradyne.com

    Contact:

    Teradyne, Inc.

    Andy Blanchard 978-370-2425

    Vice President of Corporate Relations

    SOURCE: Teradyne, Inc.

    .



    View source version on accesswire.com:
    https://www.accesswire.com/796348/teradyne-reports-third-quarter-2023- ...



    Aktuelle Themen


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    Verfasst von Accesswire
    Teradyne Reports Third Quarter 2023 Results Revenue and earnings above the mid-point of Q3 guidanceRevenue of $704 million in Q3'23, down 15% from Q3'22Robotics demand stabilized, Q3'23 revenue down 4% from Q3'22, up 20% from Q2'23Returned $136 million to shareholders in share repurchases and …

    Schreibe Deinen Kommentar

    Disclaimer